In a filing, Relay Therapeutics Inc revealed its insider Rahmer Peter unloaded Company’s shares for reported $0.14 million on Jun 05 ’24. In the deal valued at $7.06 per share,20,450 shares were sold. As a result of this transaction, Rahmer Peter now holds 432,425 shares worth roughly $2.91 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Rahmer Peter sold 40,595 shares, generating $269,551 in total proceeds. Upon selling the shares at $6.64, the insider now owns 452,875 shares.
Before that, Rahmer Peter sold 19,864 shares. Relay Therapeutics Inc shares valued at $128,520 were divested by the insider at a price of $6.47 per share. As a result of the transaction, Rahmer Peter now holds 493,470 shares, worth roughly $3.33 million.
Barclays upgraded its Relay Therapeutics Inc [RLAY] rating to an Overweight from a an Equal weight in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in mid April from “an Underperform” to “a Hold”. Raymond James also remained covering RLAY and has increased its forecast on April 19, 2023 with a “Strong buy” recommendation from previously “an Outperform” rating. Raymond James started covering the stock on April 13, 2023. It rated RLAY as “an Outperform”.
Price Performance Review of RLAY
On Tuesday, Relay Therapeutics Inc [NASDAQ:RLAY] saw its stock fall -2.32% to $6.74. Over the last five days, the stock has lost -4.94%. Relay Therapeutics Inc shares have fallen nearly -38.78% since the year began. Nevertheless, the stocks have fallen -43.22% over the past one year. While a 52-week high of $13.32 was reached on 01/08/24, a 52-week low of $5.70 was recorded on 04/24/24. SMA at 50 days reached $6.78, while 200 days put it at $8.41. A total of 0.72 million shares were traded, compared to the trading of 4.0 million shares in the previous session.
Levels Of Support And Resistance For RLAY Stock
The 24-hour chart illustrates a support level at 6.66, which if violated will result in even more drops to 6.59. On the upside, there is a resistance level at 6.87. A further resistance level may holdings at 7.01. The Relative Strength Index (RSI) on the 14-day chart is 44.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.93%. Stochastics %K at 25.30% indicates the stock is a holding.
The most recent change occurred on February 03, 2023 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $33 price target.
